Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin

Annals of Internal Medicine

Volumn 146, Issue 3, 2007, Pages 184-187

  O'Donnell, Martin J ^a,b   Kearon, Clive ^a,c   Johnson, Judy ^a,d   Robinson, Marlene ^a,d   Zondag, Michelle ^a,d   Turpie, Irene ^a,e   Turpie, Alexander G ^a,d  

^a MCMASTER UNIVERSITY   (Canada)

^b HENDERSON RESEARCH CENTRE   (Canada)

^c HENDERSON GENERAL HOSPITAL   (Canada)

^d HAMILTON GENERAL HOSPITAL   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A;

AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; BODY MASS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; ENDOVASCULAR SURGERY; EVENING DOSAGE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOEMBOLISM; TREATMENT WITHDRAWAL; UNIVERSITY HOSPITAL; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; MIDDLE AGED; RISK FACTOR; SAMPLE SIZE;

AGED; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FACTOR XA; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RISK FACTORS; SAMPLE SIZE; THROMBOEMBOLISM; WARFARIN; WITHHOLDING TREATMENT;

EID: 33847067931     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-146-3-200702060-00007     Document Type: Article

References (16)